Journal article
Role of nicotinic acid in raising high-density lipoprotein cholesterol (HDL-C) to reduce cardiovascular risk: An Asian/Pacific consensus
PJ Barter, R O'Brien, GF Watts, J Zhu, D Hu, CC Ho, B Tomlinson, BMY Cheung, JMF Adam, A Tjokroprawiro, S Waspadji, HK Cho, KH Han, SR Kim, KK Lin, SP Chan, A Basit, AB Pizzaro-Borromeo, E Paz-Pacheco, RG Sy Show all
British Journal of Diabetes and Vascular Disease | Published : 2005
Abstract
Cardiovascular disease is a leading cause of morbidity and mortality in Asia, and the burden of disease is expected to rise further in the 21st century. As in Western populations, dyslipidaemia is an important cardiovascular risk factor in Asian people. International guidelines focus on reduction of low-density lipoprotein cholesterol (LDL-C) for prevention and treatment of coronary heart disease (CHD). However, increasing body mass index and prevalence of type 2 diabetes and metabolic syndrome in Asia have highlighted the importance of low levels of high-density lipoprotein cholesterol (HDL-C) as a coronary risk factor. Therapeutic lifestyle changes and pharmacological intervention aimed at..
View full abstract